Skip to main content
Clinical Trials/EUCTR2008-005787-13-GB
EUCTR2008-005787-13-GB
Active, not recruiting
Not Applicable

A proof of concept clinical investigation to evaluate the activity of Hedrin 4% lotion in the treatment of head lice using a 1 hour application time - Is Hedrin 4% effective in 1 hour?

Thornton & Ross Ltd0 sitesDecember 7, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head louse infestation (pediculosis capitis)
Sponsor
Thornton & Ross Ltd
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants aged 6 months and over with no upper age limit.
  • 2\. Participants who upon examination, are confirmed to have live head lice.
  • 3\. Participants who give written informed consent, or if the participant is under 16 years of age whose parent/guardian gives written informed consent to participate in the study.
  • 4\. Participants who will be available for follow up visits by study team members over the 14 days following first treatment.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Participants with a known sensitivity to any of the ingredients in Hedrin 4% lotion.
  • 2\. Participants with a secondary bacterial infection of the scalp (e.g. impetigo) or who have an active long term scalp condition (e.g. psoriasis of the scalp).
  • 3\. Participants who have been treated with other head lice products within the previous two weeks.
  • 4\. Participants who have bleached hair, or hair that has been permanently waved within the previous four weeks.
  • 5\. Participants who have been treated with the antibiotics Co\-Trimoxazole or Trimethoprim within the previous four weeks, or who are currently taking such a course.
  • 6\. Pregnant or nursing mothers.
  • 7\. Participants who have participated in another clinical study within 1 month before entry to this study.
  • 8\. Participants who have already participated in this clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials